We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
-14.92%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$3.33B
AUM Growth
-$900M
Cap. Flow
-$102M
Cap. Flow %
-3.06%
Top 10 Hldgs %
40.39%
Holding
131
New
18
Increased
46
Reduced
50
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$99.9M
2
LLY icon
Eli Lilly
LLY
+$96.3M
3
BIDU icon
Baidu
BIDU
+$65.6M
4
HSY icon
Hershey
HSY
+$47.4M
5
COST icon
Costco
COST
+$43.1M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$140M
2
INFY icon
Infosys
INFY
+$115M
3
GLOB icon
Globant
GLOB
+$90.8M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$64.6M
5
CPA icon
Copa Holdings
CPA
+$39.8M

Sector Composition

Rank Sector Weight
1 Technology 32.31%
2 Healthcare 18.51%
3 Communication Services 10.88%
4 Consumer Discretionary 9.73%
5 Financials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKIN icon
101
SkinHealth Systems
SKIN
$85.7M
$2.08M 0.06%
161,367
-87,707
-35% -$1.18M
SF
102
Stifel
SF
$12.6B
$2.06M 0.06%
55,118
-47,512
-46% -$1.97M
ACDC icon
103
ProFrac Holding
ACDC
$787M
$2.05M 0.06%
+111,800
New +$2.19M
UTHR icon
104
United Therapeutics
UTHR
$23.1B
$2.03M 0.06%
8,621
+2,052
+31% +$417K
IEFA icon
105
iShares Core MSCI EAFE ETF
IEFA
$196B
$1.75M 0.05%
+29,700
New +$1.91M
JBTM
106
JBT Marel
JBTM
$6.39B
$1.71M 0.05%
15,515
-9,976
-39% -$1.15M
CWK icon
107
Cushman & Wakefield Ltd
CWK
$3.25B
$1.66M 0.05%
108,820
-37,170
-25% -$654K
THRM icon
108
Gentherm
THRM
$1.27B
$1.54M 0.05%
24,685
-720
-3% -$48.5K
ZWS icon
109
Zurn Elkay Water Solutions
ZWS
$8.53B
$1.49M 0.04%
54,565
-89,430
-62% -$2.71M
FSS icon
110
Federal Signal
FSS
$7.83B
$1.4M 0.04%
39,420
-1,390
-3% -$47.8K
TWNK
111
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$1.3M 0.04%
61,425
-313,895
-84% -$6.79M
IPI icon
112
Intrepid Potash
IPI
$469M
$1.24M 0.04%
27,375
-23,585
-46% -$1.72M
CUBI icon
113
Customers Bancorp
CUBI
$2.77B
$1.17M 0.04%
34,385
-30,525
-47% -$1.24M
AZTA icon
114
Azenta
AZTA
$1.48B
$1.08M 0.03%
15,036
-25,613
-63% -$1.91M
TYL icon
115
Tyler Technologies
TYL
$12.8B
$372K 0.01%
1,120
ADM icon
116
Archer Daniels Midland
ADM
$36.9B
-10,650
Closed -$961K
ALGN icon
117
Align Technology
ALGN
$12.3B
-86,375
Closed -$37.7M
CIB icon
118
Grupo Cibest SA
CIB
$21.1B
-67,880
Closed -$2.9M
CPA icon
119
Copa Holdings
CPA
$5.8B
-476,365
Closed -$39.8M
DKS icon
120
Dick's Sporting Goods
DKS
$18.7B
-12,071
Closed -$1.21M
EWM icon
121
iShares MSCI Malaysia ETF
EWM
$332M
-39,800
Closed -$1.02M
HRI icon
122
Herc Holdings
HRI
$5.61B
-35,703
Closed -$5.97M
IBN icon
123
ICICI Bank
IBN
$108B
-127,400
Closed -$2.41M
PGNY icon
124
Progyny
PGNY
$2.2B
-104,637
Closed -$5.38M
STM icon
125
STMicroelectronics
STM
$50B
-346,300
Closed -$15M

Similar funds

Axiom Investors's Q2 2022 Portfolio in Review

As of Q2 2022, Axiom Investors held 131 positions worth $3.33B, down 21% from $4.23B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Axiom Investors withdrew a net $102M in Q2 2022, closing 16 positions and reducing 50 holdings. Its most notable exit was Copa Holdings, an estimated $39.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 44% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Axiom Investors opened a new position in AstraZeneca worth $101M.

  • Axiom Investors's largest Q2 2022 buy was AstraZeneca: 761,253 shares worth $101M.
  • Axiom Investors added most to Baidu in Q2 2022, an estimated $65.6M increase.
  • Axiom Investors's biggest Q2 2022 reduction was TSMC, cutting an estimated $140M.
  • Axiom Investors fully exited Copa Holdings in Q2 2022, selling an estimated $39.8M.
  • Axiom Investors's ten largest holdings make up 40% of its $3.33B portfolio in Q2 2022.
  • Axiom Investors opened 18 new positions and closed 16 in Q2 2022.
  • Axiom Investors's portfolio value fell 21% quarter-over-quarter to $3.33B.

Based on Axiom Investors's 13F filing for Q2 2022, filed 11 Aug 2022.